Introduction
============

The unfolded protein response (UPR) is a 'check and balance' program activated upon disturbed homeostasis in the endoplasmic reticulum. Occasional but infrequent hints have documented an interplay between the UPR and iron metabolism ([@B15]; [@B16]; [@B9]; [@B13]). However, reports are few on the possible links between the UPR and iron within the brain ([@B5]; [@B11], [@B10]; [@B6]). A better understanding of this cross-talk might provide further clues regarding disease pathogenesis, given that aberrant iron metabolism and increased expression of markers of the UPR have been independently reported in several neurodegenerative diseases ([@B4]), including multiple sclerosis ([@B12]), Alzheimer's disease and Parkinson's disease ([@B7]; [@B14]). Researchers have exploited glial and neuronal mono- and dual-cultures *in vitro*, as well as *ex vivo* systems to investigate the regulation of iron within the brain \[see ([@B3]) for comprehensive review of this topic\]. As a foundation for future studies, the overall goal of this work was therefore to confirm and characterize the reciprocal relationship between UPR and iron homeostasis within our hippocampal slice-based model ([@B2]) of the accumulation of iron within the CNS.

Methods
=======

Ethics Statement
----------------

The research described was approved by the Animal Care Research Ethics Committee Filing ID 12/FEB/04) and was carried out in accordance with European directive 2010/63/EU.

Hippocampal Slice Culture and Reagent Exposure
----------------------------------------------

Neonatal hippocampal slices were maintained as previously described ([@B2]).

Five μg/ml tunicamycin (Tm, T7765, Sigma-Aldrich, Dublin, Ireland) exposure was used to activate a UPR response, while iron loading was induced by a 12-h treatment with 1 μM ferrocene, a membrane-permeable compound that enables uptake of iron by cells (F408, Sigma-Aldrich, Dublin, Ireland). Slices were harvested immediately after iron loading.

Analysis of RNA Transcripts
---------------------------

RNA was isolated from control and treated slice cultures using TRIreagent (T9424, Sigma-Aldrich, Dublin, Ireland) as per the manufacturer's instructions. Following DNAse I treatment (18068-015, Thermofisher-Scientific, Dublin, Ireland) and cDNA synthesis using manufacturer protocol (1804014, Superscript II Reverse Transcriptase, Invitrogen, Dublin, Ireland), real-time PCR was accomplished using Applied Biosystems 4346906 MicroAmp^®^Fast Optical 96-Well Reaction Plate and Fast SYPR green master mix (applied Biosystems, 4385612) and the Step One real-time PCR System (Thermo-Fisher).

Unless otherwise indicated, oligonucleotide primer sequences (Sigma-Aldrich, Dublin, Ireland) used were designed using Primer3. Primer sequence details are summarized in the Supplementary Table [1](#SM1){ref-type="supplementary-material"}. Results were quantified using the ΔΔCT method following standardization relative to β-actin as an internal control.

Tissue Viability
----------------

Tissue viability was measured as described in [@B2], using a lactate dehydrogenase (LDH) and MTT \[3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide\] assay.

Immunohistochemistry and Imaging
--------------------------------

Tissue was fixed and stained as previously described ([@B2]). Briefly, slices were fixed in 4% paraformaldehyde (PFA) for 30 min followed by three washes in PBS and then blocked and permeabilised for 1 h with 10% normal goat serum and 0.4% Triton X-100 in PBS. Subsequently, the slices were incubated with primary antibody (for single and dual labeling) in 2.5% NGS (or 2.5% horse serum) and 0.1% Triton X-100 in PBS for 48 h at 4°C and then washed three times for 15 min before incubation with the appropriate secondary antibody at 4°C overnight. Source information and dilutions used for all antibodies is available in the [Supplementary Materials](#SM1){ref-type="supplementary-material"}. Slice cultures were mounted in Vectashield containing diamino-2-phenylindole (DAPI) (H-1200, Vector Laboratories, Peterborough, United Kingdom) to allow visualization of nuclei. Negative "no primary antibody" controls were included. Slides were stored in the dark at 4°C until imaged. All samples were imaged on a laser scanning confocal microscope (Olympus Fluoview 1000) using a 40 × oil-immersion lens (numerical aperture of 1.3).

*In silico* Analysis of UPR Transcription Factor Binding Sites
--------------------------------------------------------------

The ALGGEN PROMO algorithm^[1](#fn01){ref-type="fn"}^ was used to determine if any UPR transcription factor consensus DNA binding sequences were present within the promoter regions of genes that encode iron homeostasis regulators. Only hits that had a dissimilarity index \<15% and a random expectation \<0.5 were included in this analysis.

Statistical Analysis
--------------------

Data was analyzed using Prism 6 (GraphPad Software). All measurements were expressed as mean ± standard error of the mean (SEM) unless otherwise indicated. Normality was assessed using the Shapiro-Wilk test. Statistical analyses were carried out using Student's *t*-test, Mann-Whitney test or an ANOVA with Dunnet post-test, as appropriate, and as indicated in figure legends. Differences were considered statistically significant if *P*\<0.05.

Results
=======

UPR Transcript Expression in Cultured Slices Exposed to Ferrocene Remains Unchanged
-----------------------------------------------------------------------------------

Real-time PCR analysis of changes in the transcripts for B-cell immunoglobulin binding protein (BiP), calreticulin (CRT), X-box binding protein 1 (XBP1), activated transcription factor 6 (ATF6), activated transcription factor and C/EBP homologous binding protein (CHOP) revealed an approximate 1.4--2.1-fold increase, which was not found to be statistically significant following three replicate experiments (Figure [1A](#F1){ref-type="fig"}).

![Cross-talk between regulators of the UPR and iron homeostasis. **(A)** Real-time PCR analysis of RNA samples derived from cultured slices treated for 12 h with 1 μM ferrocene. An upward trend in the expression of BiP, CRT, XBP1, ATF6, ATF4, and CHOP was detected (*n* = 3 experimental replicates). **(B)** Increased BiP and CHOP transcripts detected following 12 h treatment with 5 μg/ml Tm (*n* = 3). Data is expressed as mean ± 95% confidence interval following completion of three experimental repeats. ^∗^denotes *p*\<0.05. **(C)** Upward trend in the expression of FTL and FTH transcripts detected following 12 h Tm treatment (5 μg/ml, *n* = 2 experimental repeats). **(D)** Effect of Tm exposure (5 μg/ml, 12 h) on iron and protein content and on tissue viability (*n* = 3 experimental replicates). Cultures were loaded with 1 μM ferrocene **(F)**, 5 μg/ml Tm or both treatments concurrently (TmF). Data is expressed as percentage of DMSO control, which is indicated by the dashed line. Values are mean + SEM from three experiments. ♢ denotes a significant difference (*p*\<0.05) when compared with DMSO and ^∗^denotes significant difference between F-treated slices and those treated with Tm or TMF (*p*\<0.05). **(E)** CHOP expression (green) was detected within the nuclei of olig2-positive cells (red) in hippocampal slices treated with Tm or TmF (lower panels), but was not seen within the Olig2-positive population of control or F-treated slices (upper panels). Scale bar = 100 μm **(F)** When cultured slices were dual-labeled using antibodies to Iba1 (red) and CHOP (green, RH panels), CHOP was not found in DMSO-exposed slices but was seen in non-Iba1-positive slices treated with F or TmF and occasionally in Iba1-positive nuclei in slices treated with Tm alone (white arrowheads). Scale bar = 100 μm**. (G)** The significant loss of oligodendrocyte-lineage cells caused by exposure to F is partially reversed when slices are co-treated with Tm or TmF (*n* = 2 experimental replicates). ♢denotes a significant difference (*p*\<0.05) when compared with DMSO; ^∗^denotes a significant difference between F-treated slices and those treated with Tm or TMF (*p*\<0.05). **(H)** Cytoplasmic expression of ATF6 (red) detected in the non-olig2-expressing cells of DMSO- and F-treated hippocampal slices (top panels). Treatment with Tm or TmF led to nuclear expression of ATF6 within olig2-positive cells (green, arrows). Scale bar = 50 μm.](fnins-12-00969-g001){#F1}

UPR Induction Does Not Increase Expression of Iron Storage Protein Transcripts
------------------------------------------------------------------------------

The ability of cultured hippocampal slices to mount a response to ER stress was confirmed when a significant increase in BiP and CHOP transcription (approximately 30-fold for both), was detected following a 12-h treatment with 5 μg/ml tunicamycin (Tm, Figure [1B](#F1){ref-type="fig"}). Tm inhibits N-glycosylation of proteins trafficked through the ER ([@B1]) hence causing a build-up of mis-folded proteins and ER stress. However, Tm was not found, after two experimental repeats, to cause a significant increase in the expression of ferritin light chain (FTL) or ferritin heavy chain (FHL) transcripts (Figure [1C](#F1){ref-type="fig"}).

UPR Activation Prevents Ferrocene-Induced Iron Accumulation and Glial Perturbations
-----------------------------------------------------------------------------------

In line with our previous findings ([@B2]), 1 μM ferrocene produced a 1.3-fold increase in the levels of iron in slice cultures when compared to vehicle (Figure [1D](#F1){ref-type="fig"}). Similarly, we confirmed that ferrocene-induced a significant 1.5-fold increase in LDH release, and, once again, did not report any iron-induced loss in metabolic activity as assessed by MTT assay (Figure [1D](#F1){ref-type="fig"}). Interestingly, concurrent exposure to 5 μg/ml Tm (TmF) resulted in amelioration in iron accumulation and toxicity (Figure [1D](#F1){ref-type="fig"}). TmF treatment led to a significant reduction in iron content and a significant decrease in LDH release, when compared with ferrocene alone, but not when compared with the DMSO control. In keeping with our data relating to FTL and FTH transcriptional expression, Tm exposure alone did not lead to a significant difference in iron content. Tm treatment alone also had no effect on tissue viability when compared to DMSO control conditions. There were no significant differences in metabolic activity as measured using an MTT assay, or in protein content between groups (Figure [1D](#F1){ref-type="fig"}).

UPR Transcription Factor Expression in Glia Following Tm and Iron Exposure
--------------------------------------------------------------------------

Classically, CHOP is upregulated in response to phosphorylation of PERK and is frequently exploited as a marker of activation of the UPR. Immunofluorescent staining demonstrated an absence of CHOP expression in control and ferrocene-treated slice cultures, but robust upregulation of CHOP in Tm-treated tissue. Dual immunofluorescent staining confirmed CHOP expression in Olig2-positive cells within Tm-treated slices, which appeared to increase when slices were co-exposed to Tm and Ferrocene (Figure [1E](#F1){ref-type="fig"}). Less frequently, CHOP was found to be present in microglia within cultured slices exposed to Ferrocene, Tm or both (Figure [1F](#F1){ref-type="fig"}). Similar to our prior finding of significantly reduced numbers of microglial endpoints, following slice treatment with F, we also found, following two experimental repeats, fewer end-points after F treatment, which was rescued when tissue was treated with TmF (data not shown). ATF6 is the second major regulator of the UPR whose protein expression we analyzed by immunofluorescence within cultured control and treated slices. While non-nuclear ATF6 was detected in control DMSO-treated cultures, an increase in nuclear ATF6 staining was observed following treatment with Tm, F, or a combination of both reagents (not shown).

In our previous study, we reported a significant loss of oligodendrocyte-lineage cells following iron loading ([@B2]). This result was confirmed here (Figure [1G](#F1){ref-type="fig"}). Intriguingly, slice exposure to Tm or TmF reversed this loss, to the extent that Olig2-lineage cells responded by increasing their number significantly (Figure [1G](#F1){ref-type="fig"}). Dual immunofluorescence was then used to determine if the localization of ATF6 expression within Olig2-positive cells was affected by the same conditions. Our images showed that while nuclear (active) ATF6 was not detectable within DMSO-treated Olig2-lineage cells, it was present in Tm-, F- or TmF-treated cultures (Figure [1H](#F1){ref-type="fig"}).

*In silico* Analysis of Putative Transcription Factor Binding Sites Within Promoter Regions of Iron-Regulatory Genes
--------------------------------------------------------------------------------------------------------------------

Using the ALGGEN PROMO algorithm to predict consensus transcription factor (TF) DNA binding sequences, we identified a number of putative binding sites for UPR-associated transcription within the promoter regions of iron homeostasis genes (Table [1](#T1){ref-type="table"}). None of the TFs were found to be commonly expressed on all the promoter regions examined. Activated transcription factor 3 (ATF3) and CCAAT-enhancer-binding protein alpha (C/EBP-α) consensus-binding sequences were found on six of the eight genes (Table [1](#T1){ref-type="table"}). Consensus sequences for XBP1, ATF and ATF2 were found within two promoter regions; the CREB consensus sequence was found on three genes and C/EBP-β was not found on any. Therefore, there was not a consistent pattern of transcription factor hits across the different genes (Table [1](#T1){ref-type="table"}).

###### 

Putative binding sites of UPR transcription factors in the promoters of genes encoding iron homeostasis proteins.

  Gene       Factor              Start   End    Dissimilarity   String         RE Equally   RE Query
  ---------- ------------------- ------- ------ --------------- -------------- ------------ ----------
  **Hepc**   ATF3 \[T01313\]     23      60     6.74            tgacacaa       0.082        0.062
             ATF3 \[T01313\]     445     45     13.48           tgctgtca       0.164        0.132
             XBP-1 \[T00902\]    379     384    6.47            atgccc         0.292        0.318
             XBP-1 \[T00902\]    448     453    1.58            tgtcat         0.220        0.231
  **FTH**    ATF3 \[T01313\]     497     504    10.12           tgacaaaa       0.222        0.225
             ATF3 \[T01313\]     521     528    10.12           tgacttca       0.222        0.225
             C/EBPα \[T00105\]   301     307    3.55            accaatc        0.137        0.225
             C/EBPα \[T00105\]   425     431    7.47            tgcaatg        0.273        0.290
             C/EBPα \[T00105\]   527     533    2.44            cattgag        0.273        0.278
             C/EBPα \[T00105\]   571     577    2.37            aattggg        0.273        0.279
             C/EBPα \[T00105\]   1063    1069   8               tccaatg        0.137        0.141
  **FTL**    XBP-1 \[T00902\]    494     499    6.48            atgagg         0.401        0.434
             C/EBPα \[T00105\]   211     217    5.58            gtcaatt        0.401        0.283
             C/EBPα \[T00105\]   754     760    5.78            gccaata        0.401        0.283
  **TfR1**   C/EBPα \[T00105\]   1609    1615   1.22            tattgag        0.345        0.420
             C/EBPα \[T00105\]   1822    1828   0               gattgag        0.345        0.334
             CREB \[T00163\]     2347    2355   3.08            tgacgtttg      0.086        0.091
  **Tf**     C/EBPα \[T00105\]   1410    1416   4.56            gacaatc        0.280        0.270
             ATF3 \[T01313\]     1040    1047   8.31            gtatgtca       0.316        0.311
             ATF3 \[T01313\]     1397    1404   10.12           tgacctca       0.456        0.445
             ATF3 \[T01313\]     1887    1894   0               ttacgtca       0.035        0.033
             CREB \[T00163\]     1886    1894   2.66            attacgtca      0.070        0.069
             ATF-2 \[T00167\]    1886    1895   4.17            attacgtcaa     0.040        0.037
             ATF \[T00051\]      1887    1898   8.419           ttacgtcaacag   0.089        0.087
  **FPN**    ATF3 \[T01313\]     2376    2383   8.31            atatgtca       0.455        0.429
             ATF3 \[T01313\]     2745    2752   8.31            atatgtca       0.455        0.429
             ATF3 \[T01313\]     3237    3244   3.37            tgacataa       0.151        0.179
             C/EBPα \[T00105\]   759     765    5.024           cacaatc        0.404        0.370
             C/EBPα \[T00105\]   777     783    3.55            gattgga        0.404        0.533
             C/EBPα \[T00105\]   1433    1439   4.56            gattggc        0.404        0.367
  **Cp**     C/EBPα \[T00105\]   74      80     8               cattgga        0.405        0.505
             C/EBPα \[T00105\]   935     941    0.54            cacaatc        0.405        0.361
             C/EBPα \[T00105\]   1421    1427   1.22            tattgag        0.405        0.361
             C/EBPα \[T00105\]   1430    1436   0.54            gattggg        0.405        0.361
             ATF3 \[T01313\]     932     939    6.74            tgacacaa       0.456        0.519
  **DMT1**   C/EBPα \[T00105\]   2       8      3.55            accaatc        0.463        0.566
             CREB \[T00163\]     3116    3124   2.664           tgacgtgat      0.116        0.119
             ATF3 \[T01313\]     2716    2723   3.372           tgacataa       0.173        0.192
             ATF-2 \[T00167\]    3115    3124   4.17            ttgacgtgat     0.065        0.075
             ATF \[T00051\]      3112    3123   5.46            gcattgacgtga   0.048        0.047
                                                                                            

Summary of the putative binding site of the UPR-associated transcription factors in the gene sequence of an iron-homeostasis molecule with a dissimilarity index \<15% and random expectation \<0.5. Transcription factors tested: C/EBP-beta, C/EBP-α, CREB, XBP1, ATF, ATF3, ATF-2, and ATF1.

Discussion
==========

In an attempt to elucidate whether or not cross-talk between iron-regulatory proteins and ER stress, we exploited our rat hippocampal slice-based model of iron accumulation. Following slice exposure to Tm, F or both, real-time PCR and fluorescent immunohistochemistry yielded the following primary findings: (1) Tm exposure does not affect the level of iron in hippocampal slices, but it triggers a UPR that appears to prevent iron overload and possibly ameliorates toxic effects of iron on oligodendrocytes and microglia; (2) iron overload causes an upward trend in the levels of transcripts encoding the major markers of the UPR, although this was not statistically significant; (3) the observation that Tm treatment led to no significant change in the expression of FTL or FTH transcripts was surprising, since the promoter regions of eight genes that encode iron-regulatory proteins, including FTL and FTH, contain putative binding sites for ER stress-associated transcription factors; (4) transcription factor ATF6 is activated following exposure of cultured hippocampal slices to Tm, F and TmF; (5) Activated ATF6 is detectable within the Tm- and TmF-treated oligodendrocycte population but rarely in similarly treated microglia.

While intriguing, it remains unclear how concurrent iron accumulation and UPR activation, demonstrated here, leads to the ameliorated accumulation of iron. Outside the brain, the main description of the intersection between the UPR and iron metabolism is the action of CHOP on hepcidin (via modulation of C/EBPα binding and/or through CREBH) in the liver and spleen ([@B9]; [@B13]) although ER stress associated chaperones calreticulin and BiP have also been implicated in iron UPR cross-talk \[reviewed in ([@B8])\]. More recently, an increase in hepcidin expression leading to accumulated iron within the brain of rats subjected to sub-arachnoid hemorrhage, was found to be regulated by CHOP ([@B17]).

Our observation that CHOP immunofluorescence appears to be increased in Olig-2 positive cells in slices that were co-exposed to Tm and Ferrocene compared with only Tm is consistent with these studies and it hints at the potential therapeutic benefit of UPR proteins induced by Tm to protect against iron-induced toxicity within oligodendrocyte lineage cells. However, further work is required to elucidate or reasonably speculate on such a mechanism.
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